(Date:12/2/2009)...., Dec. 2 TechConnect World, an ev...velopment and product integration in cleantech, na...1th deadline for technology abstracts and business...nnect World, in association with the Nano Science ...hnology and Sustainable Industries Organization (C...
(Date:12/2/2009)... 2 S*BIO Pte Ltd today announced d..., SB1518, at The American Society of Hematology 51..., Data will be presented on the clinical result... detailing its safety, tolerability and pharmacoki...ls ranging from 100 to 600 mg. These doses were ad...
(Date:12/2/2009)..., Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmaceutic... ), a leading pharmaceutical company,specializing ...f branded,generic and proprietary pharmaceuticals ...ve been included in China,s National Drug Reimburs...inistry of Human Resources and Social,Security on ...
(Date:12/2/2009)... 2 /PRNewswire-Asia/ -- The world is going through...ncertainty is part of many,businesses and industri...,relatively immune to the economic downturn, becau...ing the midst of the difficult times this year, th...urated an R&D center in Shanghai, the largest ...
Breaking Biology Technology:Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3... Corporation (Nasdaq: RGEN ) announced today tha...r, Walter C. Herlihy, Ph.D., will present at the B... 9th, 2009 at 11:30 a.m. EST at the Waldorf-Astori...e audio webcast of the presentation will be availa...nd will be archived for 30 days following the pres...
... IPC The Hospitalist Company, Inc. (Nasdaq: IPCM...mpany, announced today that management is schedule...vices Conference held in New York, NY. , , ...erence, Speakers: Adam Sin... Jeff Taylor, President and COO, ...
...em, Inc. (NYSE Alternext US: CUR) announced today ... at the 11th Annual BIO CEO & Investor Confere...orf=Astoria Hotel, New York City. , , (Logo: htt...OGO ) , , Neuralstem,s presentation is scheduled ... Time. , , The presentation will be webcast live ...
Other Biology Technology:Repligen to Present at the BIO CEO & Investor Conference Monday, February 9th, 11:30 a.m. EST 2IPC The Hospitalist Company, Inc. to Present at UBS 2009 Global Healthcare Services Conference 2Neuralstem to Present at the 11th Annual BIO CEO & Investor Conference 2Custom Protein Cloning & Expression Services (Insect) from Proteome Resources
...iversal bioinformatics software that has changed t...nique modular design of BioNumerics allows for int...pe of data employed for the characterization of or...fingerprints, 2-D protein gels, HPLC, VNTR, MLST, ...
Basement Membrane Extract Reduced Growth Factor from R&D Systems
Cultrex 3D Culture Matrix Laminin I from R&D Systems
Biology Products: